Recent B Physics Results from the Tevatron

We review recent B physics results from the CDF and Dzero experiments in p-pbar collisions at sqrt(s) = 1.96 TeV. Using a data sample of 1.4-6.0 fb-1 collected by the CDF II detector we present searches for New Physics in Bs sector and some competitive results with B-factories in the B/charm sector. In the first category we report the BR in Bs -> J/psi f0(980) decays and the time-integrated mixing probability chi-bar of B mesons. In the second category BR and Acp in doubly Cabibbo-suppressed B+- -> D0 h+- decays and time-integrated CP violation in D0 -> h+ h- are presented.Comment: To appear in the proceeding of Rencontres de Moriond, QCD and High Energy Interactions, La Thuile, March 20-27, 2011. 6 page

On the exploitation of the prawn seed Penaeus monodon along Midnapur district of West Bengal

Exploitation of prawn seed ,Penaeus monodon is common along the northern Andhra Pradesh coast. However, due to the increasing demand prawn seed collection has been introduced to the Midnapur district of Bengal. Extensive collections were reported from most of the fish landing centres of the district during June-August 1995 period

Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity

Objective: This study aimed to evaluate whether circulating levels and/or visceral adipose tissue (VAT) expression of recently described adipokines associate with histopathological severity of nonalcoholic fatty liver disease (NAFLD), independent of obesity and insulin resistance. Methods: Serum levels of adiponectin, omentin, chemerin, monocyte chemoattractant protein-1, and secreted frizzled-related protein 4 were measured using enzyme-linked immunosorbent assay in 81 patients with obesity and NAFLD and 18 lean control subjects. Expression in VAT was measured using real-time PCR and histopathological grading was scored using the NAFLD activity score (NAS). Results: When NAFLD patients were subdivided into groups with simple steatosis, borderline nonalcoholic steatohepatitis (NASH), and NASH, adiponectin serum levels and omentin expression were lower in NASH versus simple steatosis patients. Serum adiponectin was generally lower with higher histopathological grading. Chemerin VAT expression was negatively associated with NAS (r = -0.331, P = 0.022) and steatosis score (r = -0.335, P = 0.020), independent of age, BMI, and HOMA-IR. In addition, adjusting for chemerin VAT expression in a multivariate model explained part of the association between NAS and HOMA-IR. Conclusions: These findings suggest that lower VAT expression of chemerin in patients with obesity may be involved in the pathophysiology of hepatic steatosis, potentially by modulating the link between insulin resistance and NAFLD

Weight loss in nonalcoholic fatty liver disease patients in an ambulatory care setting is largely unsuccessful but correlates with frequency of clinic visits

Background and Aims: Nonalcoholic fatty liver disease (NALFD) is a leading cause of liver disease. Weight loss improves clinical features of NAFLD; however, maintenance of weight loss outside of investigational protocols is poor. The goals of this study were to characterize patterns and clinical predictors of long-term weight loss in ambulatory patients with NAFLD

Structured Rehabilitation Exercise Program in Parkinson’s Disease

Title of the article: A Study of structured rehabilitationexercise program in Parkinson’s diseaseContext: There is a growing need to address rehabilitationissues to supplement medical therapy.Aims: To assess the impact of rehabilitation interventionin the functional status and quality of life in patients withParkinson’s disease.Settings and Design: Prospective follow-up study in ateaching hospitalMaterials and Methods: Twenty-eight cases withParkinson’s Disease on a stable pharmacological regimenand moderately disabled participated in this study. Allpatients were given the same set of exercises. Duringthe first month, patients performed exercises undersupervision at the hospital and rest of the days at home.In the second and third month, patients continued thesame exercises at home. During the fourth month, patientsmaintained their usual level of physical activity butdiscontinued the exercises. All patients were evaluatedat 0, 1, 2, 3 and 4 months. Outcome measures used wereUnified Parkinson’s Disease Rating Scale (UPDRS)version 3.0, Webster step seconds product, andParkinson’s Disease Quality of Life Questionnaire(PDQL)Results: Significant improvements were observed inUPDRS section 1 (Mentation, behavior and mood),sections 2 and 6 (Activities of Daily Living), PDQLsubscales (parkinsonian symptoms, systemic symptomsand social functioning), and Webster step-seconds product.Conclusions: Systematic program of physical therapy isbeneficial in patients suffering from moderately disabledParkinson’s disease. Activities of daily living like dressing,turning in bed and walking respond favorably to exercises.Quality of life improves considerably following exercisesleading to increased social participatio

Physicians Infrequently Adhere to Hepatitis Vaccination Guidelines for Chronic Liver Disease

Background and Goals:Hepatitis A (HAV) and hepatitis B (HBV) vaccination in patients with chronic liver disease is an accepted standard of care. We determined HAV and HBV vaccination rates in a tertiary care referral hepatology clinic and the impact of electronic health record (EHR)-based reminders on adherence to vaccination guidelines.Methods:We reviewed the records of 705 patients with chronic liver disease referred to our liver clinic in 2008 with at least two follow-up visits during the subsequent year. Demographics, referral source, etiology, and hepatitis serology were recorded. We determined whether eligible patients were offered vaccination and whether patients received vaccination. Barriers to vaccination were determined by a follow-up telephone interview.Results:HAV and HBV serologic testing prior to referral and at the liver clinic were performed in 14.5% and 17.7%; and 76.7% and 74% patients, respectively. Hepatologists recommended vaccination for HAV in 63% and for HBV in 59.7% of eligible patients. Patient demographics or disease etiology did not influence recommendation rates. Significant variability was observed in vaccination recommendation amongst individual providers (30-98.6%), which did not correlate with the number of patients seen by each physician. Vaccination recommendation rates were not different for Medicare patients with hepatitis C infection for whom a vaccination reminder was automatically generated by the EHR. Most patients who failed to get vaccination after recommendation offered no specific reason for noncompliance; insurance was a barrier in a minority.Conclusions:Hepatitis vaccination rates were suboptimal even in an academic, sub-speciality setting, with wide-variability in provider adherence to vaccination guidelines. © 2013 Thudi et al